Cross-Species Organ Transplantation Market Analysis Highlights Growth To $22.65 Billion By 2030 At 8.2% CAGR

The cross-species organ transplantation market is gaining increased attention as promising advancements in biotechnology and regulatory support are paving the way for its expansion. This field holds significant potential for addressing organ shortages worldwide by utilizing organs from genetically modified animals, making it a highly anticipated area of growth in the healthcare sector.

Projected Growth Outlook of the Cross-Species Organ Transplantation Market
The global market for cross-species organ transplantation is expected to experience substantial growth, reaching a valuation of $22.65 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 8.2%. Several factors are fueling this growth, including a rise in clinical trials focused on xenotransplantation, increased funding for gene-edited animal models, stronger collaboration between biotechnology companies and transplant centers, development of advanced immunosuppressive treatments, and the broadening of regulatory policies supporting xenotransplants. Key trends likely to shape the market in the coming years include enhanced genetic engineering of donor organs, emphasis on minimizing immune rejection, advancements in organ preservation and perfusion technologies, growing investment in translational xenotransplant research, and improved regulatory and ethical oversight mechanisms.

The cross-species organ transplantation market size has grown strongly in recent years. It will grow from $15.2 billion in 2025 to $16.5 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to shortage of human donor organs, early-stage xenotransplant research initiatives, advancements in genetic engineering tools, preclinical validation of animal-derived organs, increasing transplant waiting lists.

Download a free sample of the cross-species organ transplantation market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Players Driving Innovation in the Cross-Species Organ Transplantation Market
A number of major companies are currently at the forefront of the cross-species organ transplantation industry. These include Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTherapeutics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc., Revivicor Inc., XVIVO Perfusion AB, Bridge To Life Ltd, and Transplant Genomics Inc.

Important Acquisition Expanding Capabilities of United Therapeutics
In December 2023, United Therapeutics Corporation, a US biotechnology firm specializing in xenotransplantation, acquired Miromatrix Medical Inc., another US-based company known for its work in bioengineered organs created through decellularization and recellularization methods. This acquisition aims to strengthen United Therapeutics' portfolio in developing bioengineered transplant organs and accelerate progress in their cross-species organ transplantation programs.

View the full cross-species organ transplantation market report:
https://www.thebusinessresearchcompany.com/report/cross-species-organ-transplantation-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Strategic Collaborations Shaping the Future of Xenotransplantation
Companies in this market are increasingly forming strategic alliances to facilitate regulatory approvals and accelerate innovation. For example, in February 2025, United Therapeutics partnered with eGenesis, a pharmaceutical company based in the US, to initiate clinical trials involving pig kidney transplants into human patients. These trials, approved by the U.S. Food and Drug Administration (FDA), involve genetically modified pig kidneys and aim to tackle the critical shortage of donor kidneys by providing an alternative, sustainable organ source.

Overview of Market Segmentation in Cross-Species Organ Transplantation
The cross-species organ transplantation market is segmented in the report according to product type, application, and end-user categories. Product types include Organ Preservation Solutions, Transplant Diagnostics, Xeno Products, and other related products. Applications cover various organs such as kidney, heart, liver, lung, and other medical uses. End-users consist of transplant centers, hospitals, and other healthcare facilities.

Detailed Subsegments Covering Key Areas of the Market
Within these broader segments, the market is further divided into specific subcategories. Organ Preservation Solutions are broken down into Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, and Oxygenated Perfusion Solutions. Transplant Diagnostics include Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), and Immunological Monitoring Assays. The Xeno Products segment features Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, and Immunosuppressive Regimens tailored for xenotransplants. Lastly, Other Product Types include devices and equipment such as Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments for Transplantation, and Post-Transplant Monitoring Devices.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.